Phase Forward Inc.

As CEO, Bob Weiler has piloted Phase Forward since 2002, guiding the company to its current position as a leading provider of integrated data management solutions for clinical trials and drug safety. In 2004, Bob lead the company to a successful public offering. Under Weiler's leadership, Phase Forward acquired Lincoln Technologies in August 2005, adding innovative products and services for strategic pharmacovigilance, clinical trials signal detection and applied data standards to the company's portfolio. Weiler has more than 30 years of technology-industry leadership experience, including his previous tenure as Giga Information Group's chairman, president and CEO. Earlier in his career, Weiler served as president and CEO of Eastman Software (formerly Wang Software), as well as senior vice president, worldwide sales and marketing, for Lotus Development Corporation, where he was instrumental in expanding the company's Lotus Notes business. Weiler currently serves on the boards of the Waterville Valley Company and SADD (Students Against Destructive Decisions), and he previously served on the boards of directors of Saint Anselm's College, Corporate Software, Distributed Management Systems, Cullinet Software, Interleaf, DataLogix, and Giga Information Group. Weiler is known broadly in the information-technology community, in part for the monthly InformationWeek column he authored. Weiler received a B.A. from Saint Anselm's College, where he additionally received an honorary doctorate in 2000. In 2006, he was named to the prestigious PharmaVOICE 100 list, and he was also named 2006 CEO of the Year by the Massachusetts Technology Leadership Council, an award that honors individuals who best exemplify leadership and excellence in business and technology. Subsequent to this award, Weiler was invited to become a trustee of the Council.

Tim Rochford has developed commercial application and technology software for 20 years, including speech technology platforms, expert systems, and natural language processing systems. At Phase Forward, he is responsible for developing the company’s product strategy and architectural direction, leveraging emerging technologies to meet ever-changing market requirements. Prior to Phase Forward, Rochford provided strategic technology consulting services to a customer relationship management hosting provider and a call-center platform vendor. Rochford also served as CTO and co-founder of iConverse, an award-winning mobile application platform vendor, and as director of architecture at Infinium Software, a Web-based enterprise applications provider. Rochford holds a bachelors degree in mathematics from the University of Rhode Island. He also holds several software patents in the U.S. and worldwide.

Jason Reynolds has been working in new business development and management at Phase Forward since 1998. In his current position, he leads the North American sales operation and is responsible for customer relationship management. He has been instrumental in developing the sales organization personnel, and establishing the key processes and strategies to support the growth of the organization since its initial public offering in July of 2004. Reynolds has 15 years of experience working in the biopharmaceutical and software industries. Prior to joining Phase Forward he held senior sales positions at G.D. Searle and Indevus Pharmaceuticals. Reynolds holds a Bachelor of Science degree in Marketing from Fairfield University.

With over 20 years of experience in the pharmaceutical industry, Michael Owings joined Phase Forward as Senior Manager, Corporate Quality Affairs, later assuming responsibility as Director, Quality and Regulatory Compliance, North America. He is responsible for ensuring that the organization is in compliance with the Phase Forward Quality Charter, and relevant government and industry regulations for the delivery of Phase Forward software products and consulting services. Before joining Phase Forward, Owings held positions in large and small pharmaceutical companies. There he focused on the implementation of quality systems and the validation of computer systems in support of drug development/data acquisition, as well as manufacturing. For over 15 years, Owings worked for Marion Merrell Dow (HMR/Aventis), during which he completed such duties as implementing quality systems and validating software. Owings holds a bachelor of science degree in chemistry from the University of Missouri.

Steve Powell manages Phase Forward’s worldwide sales operation, capitalizing on his extensive knowledge of the global pharmaceutical market and hands-on experience in the broader health care market to develop new business strategies and long-term customer relationships. He is also responsible for all of Phase Forward’s extensive Commercial Services and Support operations outside of North America. Before joining Phase Forward, Powell served Glaxo Wellcome for 16 years. A chartered accountant, he joined Glaxo's generics division in 1983, undertaking a number of increasingly senior finance and operational roles, in a variety of Glaxo companies. In 1995, Powell began fulfilling a number of global roles, including directing worldwide manufacturing and supply strategy, coordinating worldwide business development activities, and leading a joint clinical-development venture with a global IT player. Late in 1997, Powell assumed responsibility for running three of the company's five United Kingdom business units and leading the business development organization.

With more than 25 years in the software industry, Steve Rosenberg has extensive experience developing and delivering innovations in health care technology, sales force automation, expert systems software, and database and application software. At Phase Forward, Rosenberg oversees product development, product management, the North American services organization and the company's worldwide production hosting operation. Rosenberg joined Phase Forward following his most recent post as vice president of client services and product management at AptSoft Corporation, a provider of enterprise solutions for business process coordination. Prior to that, Rosenberg served as senior vice president of development and client services at W3Health, where he led the development and implementation of the company's flagship health care analytics ASP environment. Rosenberg's career has included leadership roles at McKessonHBOC (formerly HPR, Inc.), Sales Technologies (a division of Dun & Bradstreet), and TRINZIC (formerly AICorp). In addition to his professional work, Rosenberg serves as Chairman of the board of trustees for St. Ann's Home, a school and residential facility for disturbed and abused children.

Mr. Lawlor has over fifteen years operating experience in the biotechnology industry in finance, business development, mergers and acquisitions, and general management. Before joining HealthCare Ventures, he was Chief Operating Officer of LeukoSite, Inc. Prior to joining LeukoSite, Mr. Lawlor was Chief Financial Officer and Vice President of Corporate Development for Alpha-Beta Technology. He was previously Chief Financial Officer and Vice President of Business Development of BioSurface Technology. He received a Master's Degree in Management from Yale University. He joined HCV in 2000.

Bobby Goswami is a general partner at ABS Capital Partners where he focuses on investment opportunities in the technology and business services sectors. Since joining ABS, Mr. Goswami has worked with leading technology solutions providers in the portfolio such as OTG Software, Inc. (now EMC Corporation), Double-Take Software, Inc. and Emptoris, Inc., helping these companies to refine their business strategy, address new markets and position themselves for liquidity. Prior to joining ABS, Mr. Goswami was a member of the Alex. Brown Technology Investment Banking Group, where he specialized in mergers and acquisitions. In all, he has nearly ten years of investment banking experience with Alex. Brown, Merrill Lynch and Goldman Sachs in equity and fixed income financing, as well as M&A. Before entering investment banking, Mr. Goswami spent four years in the systems practice at Andersen Consulting. Mr. Goswami graduated from the Massachusetts Institute of Technology and the Tuck School of Business at Dartmouth College.

Dennis Shaughnessy is a faculty member at Northeastern University in Boston. Shaughnessy was appointed to the position of Executive Professor within the University's College of Business Administration in January 2005. He teaches in the areas of compliance, governance and ethics; intellectual property; and strategic innovation and entrepreneurship. He also teaches courses in the management of life sciences enterprises. He is active in the emerging field of social innovation and entrepreneurship, where he directs several microfinance projects. Shaughnessy serves as a director of several privately-held companies, and is also an advisor to numerous entrepreneurs. Prior to joining Northeastern University, Shaughnessy was a senior executive with Charles River Laboratories International, Inc., a company that provides enabling products and services to the global pharmaceutical, biotech and medical device industries. He was the company's senior executive responsible for corporate development and strategic growth through acquisitions, strategic alliances, joint ventures, technology licensing, and new venture creation. During his tenure, Charles River grew from $100 million in annual revenues to more than $1 billion, completing numerous successful acquisitions, a management-led leveraged buy-out and an initial public offering. Shaughnessy was also responsible for the global legal affairs of the company, including corporate governance and compliance, and intellectual property management.

Gary Haroian has served on the Network Engines board of directors since June 2003. He also works as a consultant and advisor to technology companies. Most recently, Gary served as chief financial officer, chief operating officer and interim chief executive officer at Bowstreet Software. Previously, he served as senior vice president of finance and administration and chief financial officer at Concord Communications Inc. and held executive positions at Stratus Technologies Inc. Gary also serves as director for Aspen Technology, Inc. and Silverback Technologies, Inc.